BioVie Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
BioVie Inc. (BIVI) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $0 for the 3-month period ending 2016-09-30, per its 10-Q/A filed 2017-01-19.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2017-01-19
- BioVie Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2016-09-30 was $0.00.
- BioVie Inc. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2015-09-30 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month |
|---|---|
| 2016-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |